Abstract
For approximately 50 years, hepatic clearance of indocyanine green (ICG) has been used to assess liver function. Steady-state infusion of ICG with simultaneous measurement of arterial and hepatic venous ICG concentrations provides unambiguous measures of the extraction ratio for ICG and the hepatic blood flow rate, but also requires cannulation of a hepatic vein. Transient clearance following injection of a single bolus of ICG, which typically involves only measurement of arterial ICG concentration, is a more commonly used procedure. Since drawing blood from a hepatic vein is often impossible, and, in any event can be difficult, there has been considerable interest in the claim by Grainger et al. (Clin Sci 64:207–212, 1983) that a single-bolus, two-compartment model “enabled the hepatic extraction ratio (ERss) of dye to be determined solely from the plasma disappearance curve”. The principal purpose of this paper is to show that the claim by Grainger et al. is not valid because it ignores the fact that a finite fraction of ICG entering the liver passes directly into hepatic veins without being sequestered in the liver. A valid relationship between ERss and parameters determined from single-bolus clearance data is derived in this paper. For individuals with normally functioning livers, the single-bolus method of Grainger et al. yields an extraction ratio approximately 20% too large, but in cirrhotic patients with extensive intrahepatic shunting, the extraction ratio evaluated using the single-bolus method of Grainger et al. may be too large by a factor of two.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Transient removal of the tricarbocyanine dye, indocyanine green (ICG) from blood has been used for a half century as an indicator of liver function. In some applications, especially recently with the development of near-infrared spectroscopy, a gross measure of transient clearance following injection of a single bolus of ICG is correlated with a particular aspect of liver disease. Those applications are not particularly dependent on details of the theoretical basis for ICG clearance. In other applications when the value of a specific physiological quantity, such as hepatic blood flow rate, is derived from clearance data, it is essential that the procedure employed and the computations performed properly employ the underlying theory. This paper is primarily concerned with applications of the second kind.
The experimentally determined, time-dependent concentration of ICG in systemic plasma, [ICG]p, following injection of a single bolus of dye generally decreases exponentially defined by a four-parameter function of the form [see Wiegand et al. (1960)],
Connection between physiological quantities and the four parameters in Eq. 1 is provided by a linear physical model such as the two-compartment model developed in 1959 by Richards et al. Although they investigated the clearance of bromsulphthalein from dogs, their model is conceptually the same as a two-compartment model often used to analyze ICG clearance.
In 1983, Grainger et al. published a relationship between the four empirically derived parameters, a p, α, b p, and β, and a “steady-state extraction ratio (ERss)” defined as follows:
in which [ICG]hv is the concentration of ICG in hepatic venous blood, and ERss is the fraction of ICG extracted whenever the amount of ICG in liver is not changing with respect to time, which can be either at the moment when ICG in the liver reaches its maximum value following injection of a single bolus of ICG, or during steady-state, continuous injection of ICG. Grainger et al. claimed that “This analysis enabled the hepatic extraction ratio (ERss) of dye to be determined solely from the plasma disappearance curve”. Unfortunately, their claim is not supported either by their own experimental data or by the results of subsequent experimental studies (Clements et al. 1987; Burns et al. 1990).
In this paper, we show that when one derives from first principles the equations employed by Grainger et al. and compares computed [ICG]hv values with measured values reported in the literature, it is apparent that something is wrong with the model. The analysis presented in this paper identifies the source of difficulty as the assumption by Grainger et al. that ICG is totally extracted from blood and is only released into hepatic veins after sequestration in the liver although, in fact, a fraction of ICG always passes directly through the liver (Leevy et al. 1962).
Theoretical analysis
The two-compartment model used in this analysis and by others in previous analyses is represented schematically in Fig. 1. Even though certain details of ICG sequestration in the liver remain unclear, studies by Meijer et al. (1984, 1988) confirmed for ICG clearance in humans what Richards et al. and others (for example, Brauer and Pessotti 1950) had previously demonstrated for bromsulphthalein clearance in dogs. The studies by Meijer et al. clearly establish that ICG sequestered in the liver is removed in bile at a rate proportional to the amount of dye in the liver. A more recent study supporting the two-compartment model was conducted by Shinohara et al. (1995) who used near-infrared spectroscopy to measure the ICG concentration in livers of rabbits following injection of a bolus of dye. As predicted by the model, they observed that ICG in the liver increases to a maximum before decreasing exponentially.
Basic assumptions
The two-compartment model is based on the following assumptions:
-
1.
ICG in blood binds almost exclusively to plasma proteins, principally albumin.
-
2.
The concentration of ICG in peripheral veins is the same as the concentration in the hepatic artery and portal vein. In other words, systemic blood can be treated as a well-mixed pool in which the dye concentration is uniform. That assumption is only valid several minutes after injection of the bolus.
-
3.
The healthy liver has considerable capacity for sequestering ICG at sites that are not well defined.
-
4.
ICG is removed from the body exclusively through bile at a rate proportional to the ICG content of the liver.
-
5.
The concentration of ICG in hepatic venous blood is a linear function of the ICG content of the liver and that of arterial blood.
Definition of relevant variables in a consistent set of units
-
Xp = Vp [ICG]p = amount of ICG in circulating plasma, mg
-
Xl = amount of ICG sequestered in the liver, mg
-
Vp = systemic plasma volume, ml
-
[ICG]p = concentration of ICG in circulating plasma, mg/ml of plasma
-
[ICG]hv = ICG concentration in hepatic venous blood, mg/ml plasma
-
ER = extraction ratio of ICG by the liver = \( {\frac{{\left[ {\text{ICG}} \right]_{\text{p}} - \left[ {\text{ICG}} \right]_{\text{hv}} }}{{\left[ {\text{ICG}} \right]_{\text{p}} }}}, \) dimensionless
-
PFh = rate of plasma flow through the liver, ml/min
-
Qbile = k20Xl = rate of removal of ICG from the liver in bile, mg/min
-
k20Xl = rate at which ICG sequestered in the liver is released into bile, mg/min
-
k21Xl = rate at which ICG sequestered in the liver is released into venous blood, mg/min
-
η = fraction of ICG that passes directly through the liver, dimensionless
-
I = rate of infusion of ICG into an artery or vein, mg/min
-
D = ICG dose injected in a bolus = \( \int\limits_{0}^{\Updelta t} {I{\text{d}}t} , \) mg
-
Δt = time required to inject the bolus, min
Basic equations
Material balances for ICG in the two compartments are expressed as follows: for ICG in systemic blood,
and for ICG sequestered in liver,
where
In formulating Eqs. 3 and 4, we have assumed that [ICG]hv and Q bile increase linearly as X l increases. Although the form of the assumed relationships cannot be established directly, three studies indicate that the system is overall linear, which implies that the relationship between [ICG]hv, [ICG]p and [ICG]l is also linear. For example, Leevy et al. (1962) observed no significant difference in the extraction ratio or percentage ICG clearance rate when three different bolus sizes (0.15, 0.25, and 0.5 mg of ICG per kg body weight) were injected into two normal subjects. Similarly, Meijer et al. (1988) measured [ICG]p and the bilary excretion rate in post-cholecysystectomy patients following injection of 0.5, 1.0, and 2.0 mg of ICG/kg body weight. Data for the two smaller doses were in all respects consistent with the assumption that [ICG]hv and Q bile are linear functions of X p and X l. A subsequent study by Soons et al. (1991) also supports that assumption. Their study tested linearity in two different ways. They observed that steady-state values of [ICG]p were proportional to the rate of infusion for three different infusion rates, 0.5, 1.0, and 2.0 mg/min. They also measured the incremental change in [ICG]p following the injection of 0.5 mg/kg of dye while dye was continuously infused at 1.0 mg/min. Fifty minutes separated injection of successive boluses. An analysis of their data, which is not included in this paper, indicates that the transient responses were consistent with an assumption that [ICG]hv and Q bile are linearly related to X l. Therefore, it is reasonable to assume that
and
where η, k 20, and k 21 are constants. Since η and PFh occur as products in Eqs. 4 and 5, neither factor can be determined from experimental data involving only [ICG]p.
Equations 3 and 4 have the same form as equations used by Richards et al. (1959) and Clarkson and Richards (1967) in analyses that provided the theoretical basis for the paper by Grainger et al. (1983). The difference between the current paper and previous papers lies in the physical interpretation of the parameter, k 12. In previous papers, either k 12 was not explicitly defined, or it was assumed that k 12 = PFh/V p. Since Richards, and Clarkson and Richards employed a definition not specifically related to PFh, their definition of a parameter corresponding to k 12 could include the definition in Eq. 5. On the other hand, the definition of k 12 employed by Grainger et al. (1983) specifically assumes that η = 0.
Equations 3 and 4 must be solved subject to appropriate initial conditions. If dye concentrations in blood and the liver are both zero at time = 0 and dye is injected sufficiently rapidly, we have
and
One can establish by substitution that when I = 0, Eqs. 3 and 4 have solutions of the form
and
in which
and
Evaluation of the extraction ratio
To determine ER, one needs the values of k 12, k 20, and k 21, which can be computed from values of α, a p, β, and a p. We have from Eq. 3 in the limit as \( t \to 0 \)
In addition, straightforward calculation using Eqs. 12 and 13 establishes that
and
The extraction ratio for the liver is defined in terms of ICG concentrations as follows:
Since X l/X p increases with increasing time, ER decreases as ICG is transferred from circulating blood to the liver.
Even though ER is a function of time, investigators tend to think in terms of a single extraction ratio that presumably exists during their experimental procedure. A unique value is the extraction ratio during steady infusion of dye. Clarkson and Richards (1967) noted that when X l is unchanging, the two-compartment model yields a simple relationship between ER and the parameters, k 20 and k 21. In that case, it follows from Eq. 4 that
Combining Eqs. 19 and 20 yields the result
Note that Eq. 21 contains the factor (1 − η), which does not appear in the ERss equation of Grainger et al.
Experimental observations
Transient concentration of ICG in hepatic venous blood following injection of a single bolus of dye
The cardinal assumption in this analysis is that ICG appears in hepatic venous blood both by passing freely through the liver and by being released into venous blood after sequestration in the liver. The parameter, η, accounts for the fact that extraction of ICG from blood passing through the liver is not complete even when no ICG is sequestered in the liver. That behavior is obvious in experimental data reported by all investigators who measured [ICG]hv during a single-bolus procedure (Wiegand et al. 1960; Leevy et al. 1962; Rowell et al. 1964, 1965, 1968, Teranaka et al. 1977; Grainger et al. 1983). Those investigators observed that ICG appears in hepatic venous blood soon after injection of the bolus and decreases with increasing time. If extraction by the liver were perfect and ICG appeared in hepatic venous blood only after being sequestered and then released back into the blood stream (i. e., if η = 0), [ICG]hv would be zero initially and would increase to a maximum value in proportion to X l. However, experimental data plotted in Fig. 2 and similar data from every single-bolus study in which [ICG]hv was measured clearly show that [ICG]hv increases very quickly following injection of ICG, and then decreases roughly parallel to [ICG]p on a semi-log plot. Those data clearly establish that a fraction of ICG flowing into the liver passes directly into a venous stream. To quote Leevy, “At no time after its injection (0.5 mg of ICG per kg of body weight) was there 100 percent hepatic extraction of ICG; during the decelerated phase of removal of dye from plasma, the extraction ratio exhibited a further decrease”.
Extraction ratio for ICG
Grainger et al. (1983) determined directly the extraction ratio in 11 baboons by simultaneously withdrawing blood samples from a peripheral vein and a right hepatic vein. Results shown in Fig. 3 of their paper unambiguously indicate that ER measured 8 min after injection of the dye was lower than ER measured 4 min after injection, as predicted by Eq. 19.
Grainger et al. also compared values of ERss determined in two ways: using the first relationship in Eq. 19 with values of [ICG]p and [ICG]hv measured at the moment when X l has its maximum value, and computed using the second relationship in Eq. 19 with η = 0. As shown in Fig. 3, values determined using the single-bolus method tend to be larger than corresponding values determined from measurement of [ICG]p and [ICG]hv. The mean value of the ratio, ERss, single bolus/ERss, direct measurement, is 0.87, which corresponds to a mean value of η = 0.13.
Clements et al. (1987) and Burns et al. (1990) compared values of ERss determined by continuous infusion with values determined by injection of a single bolus, and concluded that the single-bolus method is definitely not applicable to subjects with cirrhotic livers. As shown in Table 1, extraction ratios determined by the single-bolus method were several times larger than ratios determined by continuous infusion, and hepatic flow rates were correspondingly smaller. A reasonable explanation for the disparity between corresponding extraction ratios is the failure to include the factor (1 − η) in the computation of ERss from single-bolus data. It is well known that intrahepatic shunting accompanies liver cirrhosis, with the value of η increasing as the degree of shunting increases. Since the error in the value of ERss from assuming that η = 0 increases as η increases, it is not surprising that attempts to apply the method of Grainger et al. to patients with liver disease were unsuccessful.
Plasma volume and hepatic perfusion rate
Of the three parameters, k 12, k 20, and k 21, derivable from transient [ICG]p data, only k 12 is directly related to PFh. We have
Using Eq. 22 to evaluate PFh requires values of V p and η. It is possible to evaluate V p from ICG clearance data as follows:
Unfortunately, it is not possible to evaluate η without measuring [ICG]hv. It follows from Eq. 6 that
because X l = 0 at t = 0.
The single-bolus method was used correctly by several early investigators who determined the hepatic extraction ratio and blood flow rate by measuring the concentration of ICG in arterial and hepatic venous blood (Wiegand et al. 1960; Rowell et al. 1964, 1965, 1968). However, it has also been used incorrectly by recent investigators who measured only [ICG]p and assumed that the relationship proposed by Grainger et al. (1983) to evaluate ERss is valid (Kenney and Ho 1995; Ho et al. 1997; Minson et al. 1998; Proctor et al. 2001). In some of the cited papers, only a relative value of PFh was reported, such as the ratio of hepatic blood flows during exercise and rest. In that case, the extraction ratio cancels out and it doesn’t matter what value is used.
Conclusions
The two-compartment model for hepatic clearance of a dye such as bromsulphthalein or indocyanine green following injection of a single bolus was introduced more than 50 years ago and has been used since then in various ways. While early applications that employed simultaneous measurement of arterial and hepatic venous concentrations of dye yielded valid results, more recent applications that did not measure the hepatic venous concentration yielded incorrect values for the extraction rate and hepatic blood flow rate. The analysis presented in this paper establishes that hepatic extraction ratios computed using the relationship proposed by Grainger et al. (1983) are too large because they fail to account for direct passage of dye through the liver. That omission provides a logical explanation for the large difference between extraction ratios measured by continuous infusion and single-bolus injection in patients with liver disease.
Contrary to the claim of Grainger et al., it is not possible to determine the extraction ratio from single-bolus data without measuring the hepatic venous concentration of dye, and the hepatic blood flow rate cannot be determined from ICG clearance data if the extraction is unknown.
References
Brauer RW, Pessotti RL (1950) Hepatic uptake and biliary excretion of bromsulphthalein in the dog. Am J Physiol 162:565–574
Burns E, Triger DR, Tucker GT, Bax NDS (1990) Indocyanine green elimination in patients with liver disease and in normal subjects. Clin Sci 80:155–160
Clarkson MJ, Richards TG (1967) Steady-state plasma clearance of bromsulphthalein and indocyanine green by single injection. Res Vet Sci 8:454–462
Clements D, West R, Elias E (1987) Comparison of bolus and infusion methods for estimating hepatic blood flow in patients with liver disease using indocyanine green. J Hepatol 5:282–287
Grainger SL, Keeling PWN, Brown IMH, Marigold JH, Thompson RPH (1983) Clearance and non-invasive determination of the hepatic extraction of indocyanine green in baboons and man. Clin Sci 64:207–212
Ho C-W, Beard JL, Farrell PA, Minson CT, Kenney WL (1997) Age, fitness, and regional blood flow during exercise in the heat. J Appl Physiol 82:1126–1135
Kenney LW, Ho C-W (1995) Age alters regional distribution of blood flow during moderate intensity exercise. J Appl Physiol 79:1112–1119
Leevy CM, Mendenhall CM, Lesko W, Howard MM (1962) Estimation of hepatic blood flow with indocyanine green. J Clin Invest 41:1169–1179
Meijer DKF, Blom A, Weitering JG, Hornsveld R (1984) Pharmacokinetics of the hepatic transport of organic anions: influence of extra- and intracellular binding on hepatic storage of dibromosulfopthalein and interactions with indocyanine green. J Pharmacokinet Biopharm 12:43–65
Meijer DKF, Weert B, Vermeer GA (1988) Pharmacokinetics of biliary excretion in man. VI. Indocyanine green. Eur J Clin Pharmacol 35:295–303
Minson CT, Wladkowski SL, Cardell AF, Pawelczyk JA, Kenney WL (1998) Age alters the cardiovascular response to direct passive heating. J Appl Physiol 84:1323–1332
Proctor DN, Miller JD, Dietz NM, Minson CT, Joyner MJ (2001) Reduced submaximal leg blood flow after high-intensity aerobic training. J Appl Physiol 91:2619–2627
Richards TG, Tindall VR, Young A (1959) A modification of the bromosulphthalein liver function test to predict the dye content of the liver and bile. Clin Sci 18:499–511
Rowell LB, Blackmon JR, Bruce RA (1964) Indocyanine green clearance and estimated hepatic blood flow during mild to maximal exercise in upright man. J Clin Invest 43:1677–1690
Rowell LB, Blackmon JR, Martin RH, Mazzarella JA, Bruce RA (1965) Hepatic clearance of indocyanine green in man under exercise and thermal stress. J Appl Physiol 20:384–394
Rowell LB, Brengelmann GL, Blackmon JR, Twiss RD, Kusumi F (1968) Splanchnic blood flow and metabolism in heat stressed man. J Appl Physiol 24:475–484
Shinohara H, Tanaka A, Kitai T, Yanabu N, Inomoto T, Satoh S, Hatano E, Yamaoka Y, Hirao K (1995) Direct measurement of hepatic indocyanine clearance with near-infrared spectroscopy: separate evaluation of uptake and removal. Hepatology 23:137–144
Soons PA, de Boer A, Cohen AF, Breimer DD (1991) Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green. Br J Clin Pharmacol 32:697–704
Teranaka M, Worthington G, Schenk JR (1977) Hepatic blood flow measurement. A comparison of the indocyanine green and electromagnetic techniques in normal and abnormal flow states in the dog. Ann Surg 185:58–63
Wiegand BD, Ketterer SG, Rapaport E (1960) The use of indocyanine green for the evaluation of hepatic function and blood flow in man. Am J Dig Dis 5:427–436
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by Susan Ward.
Rights and permissions
About this article
Cite this article
Wissler, E.H. Identifying a long standing error in single-bolus determination of the hepatic extraction ratio for indocyanine green. Eur J Appl Physiol 111, 641–646 (2011). https://doi.org/10.1007/s00421-010-1678-1
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00421-010-1678-1